The goal of the CAMPERR Study is to support the development of an investigational blood test to detect cancer at early stages when treatment may be more effective.
Currently we don’t have the tools to screen for many common cancers—such as pancreatic, ovarian, liver, and kidney cancers. These cancers are often not diagnosed until symptoms present, when the cancer is in later stages.
A single blood test that can detect many types of cancers at early stages before symptoms present may enable more lives to be saved.